Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53 gene status and human papilloma virus infection in response to platinum plus taxane-based chemotherapy of epithelial ovarian carcinomas.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology - 1 Jan 2000

Malisic E, Jankovic R, Jakovljevic K, Radulovic S

Abstract excerpt

PURPOSE: Lack of symptoms in early stages of disease and resistance to chemotherapy make epithelial ovarian carcinomas one of the most lethal neoplasms among gynaecological malignancies. The aim of this study was to analyse the impact of TP53 mutations, codon 72 polymorphism and human papillomavirus (HPV) infection on the response to platinum-taxane combination chemotherapy in patients with epithelial ovarian...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Carboplatin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Ovarian Epithelial

Share to Disease-Free Survival

Share to Neoplasms, Glandular and Epithelial

Share to Paclitaxel

Share to Papillomaviridae

Share to Papillomavirus Infections

Source

Identifiers

PMID: 22331725

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 gene status and human papilloma virus infection in response to platinum plus taxane-based chemotherapy of epithelial ovarian carcinomas.PMID 22331725Read ↗

TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer.Semantic proximity Read ↗

p53 gene alterations and human papillomavirus type 16 infection in early stages of cervical carcinoma in Serbia.Semantic proximity Read ↗

Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer.Semantic proximity Read ↗

p53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia.Semantic proximity Read ↗

Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer.Semantic proximity Read ↗

Association of Molecular Genetic Markers of TP53, MDM2, and CDKN1A Genes with Progression-Free Survival of Patients with Ovarian Cancer after Platinum-Based Chemotherapy.Semantic proximity Read ↗

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.Semantic proximity Read ↗

Determination of Both TP53 Mutation Status and the Amount of p53 Protein has Limited Diagnostic Importance for Patients with Ovarian Cancer.Semantic proximity Read ↗

TP53 and ovarian cancer.Semantic proximity Read ↗

Association of TP53 codon 72 polymorphism with susceptibility to ovarian carcinomas in Serbian women.Semantic proximity Read ↗

Association between Molecular Genetic Markers of DNA Repair and Cell Cycle Control Genes and Response to Platinum-Based Chemotherapy in Ovarian Cancer Patients.Semantic proximity Read ↗

Evaluation of the polymorphisms in the exons 2 to 4 of the TP53 in cervical carcinoma patients from a Brazilian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.